UroGen Pharma Ltd. Made Big Gain
Thu, Jul 27, 2023 at 07:37 PM
UroGen Pharma Ltd. (URGN:NASDAQ) shot up at $17.89, representing a gain of 98.6%. On Thu, Jul 27, 2023, URGN:NASDAQ hit a New 2-Week High of $17.89. The stock appeared on our News Catalysts scanner on Thu, Jul 27, 2023 at 10:46 AM in the 'BIOTECH' category. From Thu, Jul 13, 2023, the stock recorded 60.00% Up Days and 63.64% Green Days
About UroGen Pharma Ltd. (URGN:NASDAQ)
UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies.
Top 10 Gainers:
- Statera Biopharma Inc. (STAB:NASDAQ), 616.67%
- Femasys Inc. (FEMY:NASDAQ), 130.77%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 105%
- UroGen Pharma Ltd. (URGN:NASDAQ), 98.56%
- Greenbrook TMS Inc. (GBNH:NASDAQ), 90.38%
- Tupperware Brands Corporation (TUP:NYSE), 56.32%
- Colombier Acquisition Corp. Class A (CLBR:NYSE), 54.51%
- Ultralife Corporation (ULBI:NASDAQ), 52.54%
- Carmell Therapeutics Corporation Class A Common Stock (CTCX:NASDAQ), 46%
- View Inc. (VIEW:NASDAQ), 44.36%